Study of ST-1898 in Advanced Renal Cell Carcinoma

NCT06127238 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Renal Cell Carcinoma

Interventions

DRUG: ST-1898 tablets

Sponsor

Beijing Scitech-Mq Pharmaceuticals Limited